DaBomb Protein Biotech Balance Sheet Health
Financial Health criteria checks 3/6
DaBomb Protein Biotech has a total shareholder equity of NT$958.1M and total debt of NT$416.0M, which brings its debt-to-equity ratio to 43.4%. Its total assets and total liabilities are NT$1.4B and NT$443.8M respectively.
Key information
43.4%
Debt to equity ratio
NT$415.99m
Debt
Interest coverage ratio | n/a |
Cash | NT$380.07m |
Equity | NT$958.06m |
Total liabilities | NT$443.83m |
Total assets | NT$1.40b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6578's short term assets (NT$778.8M) exceed its short term liabilities (NT$356.8M).
Long Term Liabilities: 6578's short term assets (NT$778.8M) exceed its long term liabilities (NT$87.1M).
Debt to Equity History and Analysis
Debt Level: 6578's net debt to equity ratio (3.7%) is considered satisfactory.
Reducing Debt: 6578's debt to equity ratio has increased from 10.4% to 43.4% over the past 5 years.
Debt Coverage: 6578's debt is not well covered by operating cash flow (1.6%).
Interest Coverage: Insufficient data to determine if 6578's interest payments on its debt are well covered by EBIT.